Cost-Effectiveness of Plerixafor (PXF) for Stem Cell Mobilization in Lymphoma (NHL/HL) and Multiple Myeloma (MM) Patients in Poland

Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.358
https://www.valueinhealthjournal.com/article/S1098-3015(13)02263-8/fulltext
Section Title : Disease-Specific Studies
Section Order : 338
First Page : A384
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02263-8&doi=10.1016/j.jval.2013.08.358
HEOR Topics :
Tags :
Regions :